KMT2A and acute lymphoblastic leukemia: Earlier findings revealed that short‐term exposure to high‐dose decitabine could synergize with cytarabine to eradicate MLL‐rearranged ALL cells in vitro [42], as well as with l‐asparaginase to enhance cytotoxicity in the pediatric T‐ALL [30].